Curitiba acute ischemic stroke protocol: A university hospital and EMS initiative in a large Brazilian city;Protocolo de AVCi agudo em Curitiba: Uma iniciativa de um hospital universitário e do SAMU

Arquivos de Neuro-Psiquiatria

Volumn 69, Issue 3, 2011, Pages 441-445

  Lange, Marcos Christiano ^a   Zétola, Viviane Flumignan Zétola ^a   Parolin, Monica F ^a   Zamproni, Laura N ^a   Fernandes, Artur F ^a   Piovesan, Élcio Juliato ^a   Nóvak, Edison Matos ^a   Werneck, Lineu César ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Acute ischemic stroke; Emergency medical services; Hospital management; Stroke therapy; Thrombolytic therapy

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE DISEASE; ACUTE ISCHEMIC STROKE; ADULT; AGED; ARTICLE; BLEEDING; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAZIL; CLINICAL PROTOCOL; DRUG CONTRAINDICATION; DRUG FATALITY; EMERGENCY CARE; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; RANKIN SCALE; THROMBOCYTE COUNT; UNIVERSITY HOSPITAL;

EID: 79960605771     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2011000400006     Document Type: Article

References (23)

1. Andre C, Curioni CC, Braga da Cunha C, Veras R. Progressive decline in stroke mortality in Brazil from 1980 to 1982, 1990 to 1992, and 2000 to 2002. Stroke 2006;37:2784-2789.
2. Cabral NL, Gonçalves ARR, Longo AL, et al. Trends in stroke incidence, mortality and case fatality rates in Joinville, Brasil: 1995-2006. J Neurol Neurosurg Psychiatry 2009;80:755-761.
3. Pontes-Neto OM, Silva GS, Feitosa MR, et al. Stroke awareness in Brazil: alarming results in a community-based study. Stroke 2008;39:292-296.
4. Nóvak EM, Zétola VH, Muzzio JA, Puppi M, Carraro Júnior H, Werneck LC. Lay knowledge about stroke. Arq Neuropsiquiatr 2003;61:772-776.
5. Moser DK, Kimble LP, Alberts MJ, et al. Reducing delay in seeking treatment by patients with acute coronary syndrome and stroke: a scientific statement from the American Heart Association Council on Cardiovascular Nursing and Stroke Council. Circulation 2006;114:168-182.
6. Rizos T, Ringleb PA, Huttner HB, Köhrmann M, Jüttler E. Evolution of stroke diagnosis in the emergency room: a prospective observational study. Cerebrovasc Dis 2009;28:448-453.
7. Kidwell CS, Starkman S, Eckstein M, Weems K, Saver JL. Identifying stroke in the field. Prospective validation of the Los Angeles prehospital stroke screen (LAPSS). Stroke 2000;31:71-76.
8. The National Institute of Neurological Disorders and Stroke rt-PA stroke study group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1588.
9. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337:1521-1526.
10. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECT study group. Alberta stroke program early CT score. Lancet 2000;355:1670-1674.
11. Larrue V, von Kummer R, del Zoppo G, Bluhmki E. Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study. Stroke 1997;28:957-960.
12. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-1025.
13. de Leciñana-Cases MA, Gil-Núñez A, Díez-Tejedor E. Relevance of stroke code, stroke unit and stroke networks in organization of acute stroke care: The Madrid acute stroke care program. Cerebrovasc Dis 2009;27(Suppl 1): S140-S147.
14. Boode B, Welzen V, Franke C, van Oostenbrugge R. Estimating the number of stke patients eligible for thrombolytic treatment if delay could be avoided. Cerebrovasc Dis 2007;23:294-298.
15. Naganuma M, Toyoda K, Nonogi H, et al. Early hospital arrival improves outcome at discharge in ischemic but not hemorrhagic stroke: a prospective multicenter study. Cerebrovasc Dis 2009;28:33-38.
16. Kwan J, Hand P, Sandercock P. A systematic review of barriers to delivery of thrombolysis for acute stroke. Age Ageing 2004;33:116-121.
17. Engelstein E, Margulies J, Jeret JS. Lack of t-PA use for acute ischemic stroke in a community hospital: high incidence of exclusion criteria. Am J Emerg Med 2000;18:257-260.
18. Hills NK, Johnston SC. Why are eligible thrombolysis candidates left untreated? Am J Prev Med 2006;31(Suppl):S210-S216.
19. Graham GD. Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data. Stroke 2003;34:2847-2850.
20. Hacke W, Kaste M, Fieschi C, et al. Randomized double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-1251.
21. Wahlgren N, Ahmed N, Dávalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 369:275-282.
22. Marler JR, Tilley BC, Lu M, et al. Early stroke treatment associated with better outcome. Neurology 2000;55:1649-1655.
23. Grotta J, Marler J. Intravenous rt-PA: a tenth anniversary reflection. Surg Neurol 2007;68 (Suppl):S12-S16.